Eli Lilly has priced its new migraine drug, Reyvow, at $640 for a pack of eight pills, according to PMLiVE.
Reyvow was approved by the FDA last October and became available for prescription Jan. 31.
Patients will not necessarily pay $640 for eight pills, depending on the duration of treatment and their healthcare plan.
Eli Lilly also said it will offer a Reyvow savings card to eligible patients to help them lower their out-of-pocket costs.
Read the full article here.